000 01601 a2200457 4500
005 20250513212504.0
264 0 _c20000718
008 200007s 0 0 eng d
022 _a0306-5251
024 7 _a10.1046/j.1365-2125.2000.00197.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSomer, M
245 0 0 _aInfluence of hydroxychloroquine on the bioavailability of oral metoprolol.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cJun 2000
300 _a549-54 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdrenergic beta-Antagonists
_xpharmacokinetics
650 0 4 _aAdult
650 0 4 _aAntimalarials
_xpharmacology
650 0 4 _aAntirheumatic Agents
_xpharmacology
650 0 4 _aArea Under Curve
650 0 4 _aBiological Availability
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aCross-Over Studies
650 0 4 _aCytochrome P-450 CYP2D6 Inhibitors
650 0 4 _aDextromethorphan
_xurine
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Interactions
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aHydroxychloroquine
_xpharmacology
650 0 4 _aMale
650 0 4 _aMetoprolol
_xpharmacokinetics
700 1 _aKallio, J
700 1 _aPesonen, U
700 1 _aPyykkö, K
700 1 _aHuupponen, R
700 1 _aScheinin, M
773 0 _tBritish journal of clinical pharmacology
_gvol. 49
_gno. 6
_gp. 549-54
856 4 0 _uhttps://doi.org/10.1046/j.1365-2125.2000.00197.x
_zAvailable from publisher's website
999 _c10799845
_d10799845